Skip to main content
About / À propos IKDS 2024
About - À propos
Key dates at a glance
Childcare
Registration & Hotel
Registration - Inscription
Hotel - Hébergement
Program - Programme
Schedule
Preliminary program
Simultaneous translation
Abstracts
Abstracts
Browse by Poster Title
How to sponsor or donate
Invitation to sponsor/donate
Exhibit hall booth packages
Accreditation - Agrément
Accreditation - Agrément
Certificate of Attendance
Exhibit Hall
Exhibitor Information
No Longer Available
Exhibit Hall Features
Destination : Montréal
Visit / Visitez Montréal
Travel - Transport
FAQ - Foire aux questions
Privacy Policy
Toggle navigation
Login
Search
Home
+
About / À propos IKDS 2024
About - À propos
Key dates at a glance
Childcare
+
Registration & Hotel
Registration - Inscription
Hotel - Hébergement
+
Program - Programme
Schedule
Preliminary program
Simultaneous translation
+
Abstracts
Abstracts
Browse by Poster Title
+
How to sponsor or donate
Invitation to sponsor/donate
Exhibit hall booth packages
+
Accreditation - Agrément
Accreditation - Agrément
Certificate of Attendance
+
Exhibit Hall
Exhibitor Information
No Longer Available
Exhibit Hall Features
+
Destination : Montréal
Visit / Visitez Montréal
Travel - Transport
FAQ - Foire aux questions
Privacy Policy
Icon Legend
Favorite
Like
Tweet
Print
Re-examining Use of Aspirin and Approaches to Anticoagulation
DOACs for prophylaxis and thrombolysis – Benefits for KD patients
Tuesday, August 27, 2024
3:35 PM - 3:50 PM
East Coast USA Time
Location: Montreal
Presenter(s)
CV
Christina Vanderpluym
Pediatric cardiologist
Boston, Massachusetts, United States
Back to Top